Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify 'antikeratinizing' effects of retinoids

38Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A method was developed to quantify the 'antikeratinizing' effects of various retinoids (all-trans-retinoic acid, 13-cis-retinoic acid, motretinide, etretinate) in rhino mouse skin, which contains many keratinized pilosebaceous structures or horn-filled utriculi. Mean utriculus diameters in whole mount epidermis were determined and dose-response relationships were constructed after topical or oral administration of test retinoids. All-trans-retinoic acid was 3.7x, 12.5x, and 50x more potent than 13-cis-retinoic acid, etretinate, and motretinide, respectively, after topical administration. Administration orally, all-trans-retinoic acid was 2.3x more potent than 13-cis-retinoic acid. At 5 mg/kg, each retinoid produced a significant reduction in utriculus size. The rhino mouse model represents a novel and useful assay to quantify antikeratinizing activity and potency differences of biologically active retinoids.

Cite

CITATION STYLE

APA

Mezick Bhatia, J. A. M. C., & Capetola, R. J. (1984). Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify “antikeratinizing” effects of retinoids. Journal of Investigative Dermatology, 83(2), 110–113. https://doi.org/10.1111/1523-1747.ep12263280

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free